Thomas R. Cannell
2023 - Eleven Biotherapeutics
In 2023, Thomas R. Cannell earned a total compensation of $3.1M as Former President and Chief Executive Officer at Eleven Biotherapeutics, a 125% increase compared to previous year.
Compensation breakdown
| Salary | $104,225 |
|---|---|
| Other | $3,028,485 |
| Total | $3,132,710 |
Cannell received $3M in other compensation, accounting for 97% of the total pay in 2023.
Cannell also received $104.2K in salary.
Rankings
In 2023, Thomas R. Cannell's compensation ranked 285th out of 2,978 executives tracked by ExecPay. In other words, Cannell earned more than 90.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 285 out of 2,978 | 90th |
Division Manufacturing | 155 out of 1,637 | 91st |
Major group Chemicals And Allied Products | 104 out of 906 | 89th |
Industry group Drugs | 101 out of 869 | 88th |
Industry Pharmaceutical Preparations | 65 out of 627 | 90th |
Source: SEC filing on April 29, 2024.
Cannell's colleagues
We found five more compensation records of executives who worked with Thomas R. Cannell at Eleven Biotherapeutics in 2023.
2023
Steven Kelly
Eleven Biotherapeutics
Chief Executive Officer
2023
Richard Morris
Eleven Biotherapeutics
Chief Financial Officer
2023
Michael Klichinsky
Eleven Biotherapeutics
Chief Scientific Officer
2023
Monica Forbes
Eleven Biotherapeutics
Chief Financial Officer
2023
Mark Sullivan
Eleven Biotherapeutics
General Counsel
News
Eleven Biotherapeutics CEO Steven Kelly receives $3.5M in 2023
April 29, 2024
Eleven Biotherapeutics CEO Thomas Cannell's 2022 pay falls 72% to $1.4M
April 28, 2023
Eleven Biotherapeutics CEO Thomas Cannell's 2021 pay jumps 189% to $4.9M
April 28, 2022
Eleven Biotherapeutics CEO Thomas Cannell's 2020 pay jumps 21% to $1.7M
March 25, 2021
Eleven Biotherapeutics CEO Thomas Cannell's 2019 pay falls 30% to $1.4M
March 30, 2020
Eleven Biotherapeutics CEO Thomas Cannell receives $2M in 2018
April 30, 2019